Please try another search
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Sell | Sell | Sell | Sell | Buy |
Technical Indicators | Sell | Sell | Sell | Sell | Strong Buy |
Summary | Sell | Sell | Sell | Sell | Strong Buy |
Filter Table By:
Pattern | Timeframe | Reliability | Candles Ago | Candle Time | |
---|---|---|---|---|---|
Completed Patterns | |||||
Upside Gap Three Methods | 1M | 6 | Jun 20 | ||
Three Outside Up | 1M | 8 | Apr 20 | ||
Bullish Engulfing | 1M | 9 | Mar 20 | ||
Three Outside Down | 1M | 10 | Feb 20 | ||
Engulfing Bearish | 1M | 11 | Jan 20 |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
Rolls-Royce Holdings | 401.40 | 409.00 | 393.10 | +3.60 | +0.91% | 86.12M | 17/04 | ||
Lloyds Banking | 50.42 | 50.84 | 49.62 | +0.72 | +1.45% | 134.96M | 17/04 | ||
IAG | 160.70 | 161.15 | 157.20 | +2.90 | +1.84% | 22.33M | 17/04 | ||
International Distributions Services | 276.00 | 276.40 | 212.40 | +61.80 | +28.85% | 9.34M | 17/04 | ||
Vodafone Group PLC | 66.480 | 66.960 | 65.600 | +0.420 | +0.64% | 36.18M | 17/04 | ||
HSBC | 636.10 | 641.80 | 631.20 | +4.40 | +0.70% | 15.57M | 17/04 | ||
Rio Tinto PLC | 5,388.0 | 5,449.4 | 5,317.0 | +134.0 | +2.55% | 5.08M | 17/04 | ||
Barclays | 179.94 | 181.10 | 177.46 | +1.46 | +0.82% | 51.74M | 17/04 | ||
Legal & General | 243.00 | 245.50 | 242.10 | -0.30 | -0.12% | 15.62M | 17/04 | ||
GSK plc | 1,590.00 | 1,603.00 | 1,576.00 | -20.50 | -1.27% | 6.51M | 17/04 |
genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. The company provides Genedrive system, a rapid thermocycler and signal detection system and semi- automated system used forqualitative in vitro molecular diagnostic tests; and Genedrive CYP2C19 ID Kit, a point-of-care test for rapid CYP2C19 genotyping in time-critical emergency care settings. It also offers Genedrive MT-RNR1-ID Kit, a rapid genetic test in an emergency neonatal care setting; and tests for the detection of Antibiotic Induced Hearing Loss in neonates, confirmation of HCV infection prior to drug administration, pathogen detection of biological military threats and a point-of-care for COVID-19 detection system for use in areas, such as healthcare, workplace screening, travel requirements, and confirmation of antigen tests. It serves medical, biotechnology, and pharmaceutical industries in the United Kingdom, Europe, the United States, and internationally. The company was formerly known as Epistem Holdings Plc and changed its name to genedrive plc in July 2016. genedrive plc was founded in 2000 and is headquartered in Manchester, the United Kingdom.
Read MoreAre you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review